1. Male or female patients â?¥45 years of age at the time of screening AND having History of one or more of the following risk factors at screening as evidenced by previous medical records: Diabetes and/or heart diseases and/or chronic renal disease and/or Chronic Obstructive Pulmonary disease and/or cerebrovascular diseases and/or judged to be obese with BMI > 25 <br/ > OR <br/ > Male or female patients â?¥ 65 years of age without any co-morbidity <br/ > 2. COVID-19 confirmed by molecular biology or validated antigenic test available in India for SARS-Cov2 according to national guidelines, based on result within 24 hours prior to screening and maximum 48 hours after sampling. <br/ > 3. Viral syndrome with or without uncomplicated pneumonia, defined as blood oxygen saturation level (SpO2) â?¥ 94%. <br/ > 4. Signed written consent from the patient <br/ > 5. Accepting and having the ability to be reached by telephone throughout the study <br/ > 6. Acceptability of using telemedicine platform through a application on mobile device <br/ > 7. Having designated a contact person who can be contacted in case of emergency.

1. Male or female patients â?¥45 years of age at the time of screening AND having History of one or more of the following risk factors at screening as evidenced by previous medical records: Diabetes and/or heart diseases and/or chronic renal disease and/or Chronic Obstructive Pulmonary disease and/or cerebrovascular diseases and/or judged to be obese with BMI > 25 <br/ > OR <br/ > Male or female patients â?¥ 65 years of age without any co-morbidity <br/ > 2. COVID-19 confirmed by molecular biology or validated antigenic test available in India for SARS-Cov2 according to national guidelines, based on result within 24 hours prior to screening and maximum 48 hours after sampling. <br/ > 3. Viral syndrome with or without uncomplicated pneumonia, defined as blood oxygen saturation level (SpO2) â?¥ 94%. <br/ > 4. Signed written consent from the patient <br/ > 5. Accepting and having the ability to be reached by telephone throughout the study <br/ > 6. Acceptability of using telemedicine platform through a application on mobile device <br/ > 7. Having designated a contact person who can be contacted in case of emergency.